Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome

Post-COVID syndrome develops in 10–20% of people who have recovered from COVID-19 and it is characterized by impaired function of the nervous, cardiovascular, and immune systems. Previously, it was found that patients who recovered from infection with the SARS-CoV-2 virus had a decrease in the numbe...

Mô tả đầy đủ

Chi tiết về thư mục

Những tác giả chính:	Andrei A. Savchenko, Igor V. Kudryavtsev, Dmitry V. Isakov, Ivan S. Sadowski, Vasily D. Belenyuk, Alexandr G. Borisov
Định dạng:	Artigo
Ngôn ngữ:	Inglês
Được phát hành:	MDPI AG 2023-04-01
Loạt:	Pharmaceuticals
Những chủ đề:	post-COVID syndrome NK cell recombinant human interleukin-2 immunorehabilitation subset composition functional activity
Truy cập trực tuyến:	https://www.mdpi.com/1424-8247/16/4/537
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!